LOS ANGELES, Jan. 21, 2015 (GLOBE NEWSWIRE) -- Gala Global, Inc. (OTCQB:GLAG) today announced that internationally recognized energy entrepreneur Erlend Olson and highly accomplished Pharmaceutical, Biotechnology and Medical Device expert Russell Anderson have joined the Gala Global Board of Directors. Prior to joining Gala Global, Inc., Mr. Erlend Olson spent the first 15 years of his career as a member of technical staff at NASA's Jet Propulsion Laboratory. In the late 1990's, Mr. Olson was then the founder and CTO of Pivotal Technologies, which merged with Broadcom in a transaction valued at over $600M at closing. Mr. Olson has also been involved in raising private equity and debt capital for various private companies, and is the author/holder of 38 patents, patent applications and patents pending. Mr. Russell Anderson has held senior management positions in Product Development and Process Engineering functions for several medical device and biopharma companies including Cohesion Technologies, Novare Surgical, Artes Medical, and AscentX Medical Corporation. Mr. Anderson has also served as a principal consultant for many clients including Amgen, Astute Medical, Baxter Pharmaceuticals, Boston Scientific, Genentech, Novartis, NuVasive, Roche and Sandoz. Mr. Anderson is a named inventor on over 30 patents in the medical device and biopharmaceutical fields.
"The vision of Gala Global's products offering is an inspirational and exciting venue. The vision is extraordinary and I am excited to be included with this team," stated Mr. Olson. "I look forward to working with my fellow board members. My experience brings stability and transparency, through regulation and responsible business practices. It is exciting to join this talented team and I look forward to using my extensive background to assist in the development of new opportunities for GALA Global and their shareholders," stated Russell Anderson.
"We are seeing the emergence of a new medicinal category industry. The new board members are the perfect personnel to provide direction for their ongoing activities with Gala Global in the long term direction for our goals. Each board member, including Paul Frank, has vast experience for international business success. We look forward to their enthusiastic involvement as we define our future," stated CEO George Lefevre.
About Gala Global, Inc.
Gala Global, Inc. is a publicly traded development stage company which plans to expand in the Hemp and Cannabis industries. The Company is refocusing its purpose on the development, research, and commercialization of products derived from Hemp and Cannabis Plant, while expanding the clothing operations and upcoming Hemp based fiber apparel and accessories division under the direction of the internationally recognized designer Paul Frank.
Disclaimer: The Company relies upon the Safe Harbor Laws of 1933, 1934 and 1995 for all public news releases. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the company include, but are not limited to, government regulation; managing and maintaining growth; the effect of adverse publicity; litigation; competition; and other factors which may be identified from time to time in the company's public announcements.
George R. Lefevre (702) 721-9822
